Top stories from the 2017 AMA Annual Meeting
Hundreds of physicians, medical students, residents and fellows gathered at the 2017 AMA Annual Meeting in Chicago to consider a wide array of proposals designed to help fulfill the Association's core mission of promoting medicine and improving public health. These are the top stories from the meeting. Read full coverage at AMA Wire®.
Legal synthetic drugs such as Spice are quickly emerging and difficult to track. The AMA wants new strategies and education on these new drugs of abuse.
On gun violence, health reform, mega-mergers, practice burdens and more, the AMA is taking a leadership role, says outgoing AMA President Andrew W. Gurman.
Experts on the reform discussion in Washington and value-based medicine offer their insights on the health system’s uncertain future.
Delegates address how medical licensing boards handle physicians who have sought behavioral health treatment.
While reversing the opioid epidemic remains a vital focus, AMA delegates seek strategies, education to help the millions who live with chronic pain.
Board-certified family physician David O. Barbe, MD, MHA, says the time is right for physician-style leadership that puts patients and professionalism first.
The AMA will continue collaboration with the VA, calls for new funding for the Veterans Choice Program.
LGBT-friendly, nondiscriminatory policies land backing from the AMA House of Delegates.
Delegates seek better care for detained immigrants. The AMA also votes to keep information in patient records out of immigration officials’ hands.
The AMA offers critical resources and policies, guides lifelong physician growth and helps improve the nation’s health, says AMA CEO James L. Madara, MD.
Doctors’ education, expertise and experience warrant greater participation on the boards of health care organizations, says new AMA policy.